Prostaglandin E1 reduces myocardial reperfusion injury by inhibiting proinflammatory cytokines production during cardiac surgery

Critical Care Medicine

Volumn 28, Issue 7, 2000, Pages 2201-2208

  Kawamura, Takae ^a   Nara, Noriko ^b   Kadosaki, Mamoru ^b   Inada, Katsuya ^b   Endo, Shigeatu ^b  

^a IWATE MEDICAL UNIVERSITY   (Japan)

^b NONE

Author keywords

Cardiac surgery; Cytokines; II; Interleukin 1 receptor antagonist; Interleukin 10; Interleukin 6; Interleukin 8; Prostaglandin E1; Reperfusion injury; Soluble tumor necrosis factor receptor I

Indexed keywords

CREATINE KINASE; CYTOKINE; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; PROSTAGLANDIN E1; PROSTAVASIN; TROPONIN T; TUMOR NECROSIS FACTOR RECEPTOR; VASODILATOR AGENT;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HEART PROTECTION; HEART SURGERY; HUMAN; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REPERFUSION INJURY; BIOSYNTHESIS; BLOOD; CARDIOPULMONARY BYPASS; CORONARY ARTERY BYPASS GRAFT; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; HEMODYNAMICS; IMMUNOLOGY; INTRAOPERATIVE PERIOD; MIDDLE AGED; VALVULAR HEART DISEASE;

AGED; ALPROSTADIL; CARDIOPULMONARY BYPASS; CORONARY ARTERY BYPASS; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART VALVE DISEASES; HEMODYNAMIC PROCESSES; HUMANS; INTRAOPERATIVE PERIOD; MALE; MIDDLE AGED; MYOCARDIAL REPERFUSION INJURY; VASODILATOR AGENTS;

EID: 0033623842     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-200007000-00004     Document Type: Article

References (44)

1. 1. Simpson PJ, Lucchesi BR: Free radicals and myocardial ischemia and reperfusion injury. J Lab Clin Med 1987; 110:13-30
2. 2. Colletti LM, Remick DG, Burtch GD et al: Role of tumor necrosis factor-alpha in the pathophysiologic alterations after hepatic ischemia/reperfusion injury in the rat. J Clin Invest 1990; 85:1936-1943
3. 3. Jaeschke H, Farhood A, Smith CW: Neutrophils contribute to ischemia/reperfusion injury in rat liver in vivo. FASEB J 1990; 4:3355-3359
4. 4. Grishma MB, Hernandez LA, Granger DN: Xanthine oxidase and neutrophil infiltration in intestinal ischemia. Am J Physiol 1986; 251:G567-G574
5. 5. Dreyer WJ, Michael LH, West MS, et al: Neutrophils accumulation in ischemic canine myocardium. Insights into time course, distribution, and mechanism of localization during early reperfusion. Circulation 1991; 84:400-411
6. 6. Ma X, Lefer DJ, Lefer AM, et al: Coronary endothelial and cardiac protective effects of a monoclonal antibody to intercellular adhesion molecule-I in myocardial ischemia and reperfusion. Circulation 1992; 86:937-946
7. 7. Marty C, Misset B, Tamion F, et al: Circulating interleukin-8 concentrations in patients with multiple organ failure of septic and nonseptic origin. Crit Care Med 1994; 22: 673-679
8. 8. Borrelli E, Roux-Lombard P, Grau GE, et al: Plasma concentrations of cytokines, their soluble receptors, and antioxidant vitamins can predict the development of multiple organ failure in patients at risk. Crit Care Med 1996; 24:392-397
9. 9. Clavien PA, Camargo CA Jr, Gorczynski R, et al: Acute reactant cytokines and neutrophil adhesion after warm ischemia in cirrhotic and human livers. Hepatology 1996; 23: 1456-1463
10. 10. Wan S, De Smet JM, Barvain L, et al: Myocardium is a major source of proinflammatory cytokines in patients undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg 1996; 112:806-811
11. 11. Kawamura T, Wakusawa R, Inada K: Interleukin-10 and interleukin-1 receptor antagonists increase during cardiac surgery. Can J Anaesth 1997; 44:38-42
12. 1 on transplanted kidneys in dogs by laser Doppler blood perfusion monitor. Transplant Proc 1992; 24: 1349-1350
13. 13. Sinclair S, Levy G: Eicosanoids and the liver. Ital J Gastroenterol 1990; 22:205-213
14. 14. Mizoguchi Y, Tsutsui H, Miyajima K et al: The protective effects of prostaglandin E1 in an experimental massive hepatic cell necrosis model. Hepatology 1987; 7:1184-1188
15. 15. Simpson PJ, Mickelson J, Fantone JC, et al: Reduction of experimental canine myocardial infarct size with prostaglandin E1: Inhibition of neutrophil migration and activation. J Pharmacol Exp Ther 1988; 244: 619-624
16. 16. Lou J, Buhler L, Deng S, et al: Inhibition of leukocyte adherence and transendothelial migration in cultured human liver vascular endothelial cells by prostaglandin E1. Hepatology 1998; 27:822-828
17. 17. Feldman HA: Families of lines: Random effects in linear regression analysis. J Appl Physiol 1998; 64:1721-1732
18. 18. Granger DN, Korthuis RJ: Physiologic mechanisms of postischemic tissue injury. Annu Rev Physiol 1995; 57:311-332
19. 19. Romson JL, Hook BG, Kunkel SL, et al: Reduction of the extent of ischemic myocardial injury by neutrophil depletion in the dog. Circulation 1983; 67:1016-1023
20. 20. Hernandez LA, Grisham MB, Twohig B, et al: Role of neutrophils in ischemia-reperfusion induced microvascular injury. Am J Physiol 1987; 253:H699-H703
21. 21. Rubin BB, Chang G, Liauw S, et al: Phospholipid peroxidation deacetylation and remodeling in postischemic skeletal muscle. Am J Physiol 1992; 263:H1695-H1702
22. 22. Kochanek PM, Hallenbeck JM: Polymorphonuclear leukocytes and monocytes/macrophages in the pathogenesis of cerebral ischemia and stroke. Stroke 1992; 23:1367-1379
23. 23. Barry MC, Kelly CJ, Stokes K, et al: Glyceryl trinitrate prevents neutrophil activation but not thromboxane release following ischemia-reperfusion injury. Br J Surg 1996; 83: 1095-1100
24. 24. Stokes K, Abdih H, Kelly CJ, et al: Thermotolerance attenuates ischemia-reperfusion induced renal injury and increased expression of ICAM-1. Transplantation 1996; 62: 1143-1149
25. 25. Shandelya SM, Kuppusamy P, Herskowitz A, et al: Soluble complement receptor type I inhibits the complement pathway and prevents contractile failure in the postischemic heart: Evidence that complement activation is required for neutrophil mediated reperfusion injury. Circulation 1993; 88:2812-2826
26. 26. Seekamp A, Till GO, Mulligan MS, et al: Role for selectins in local and remote tissue injury following ischemia and reperfusion. Am J Pathol 1994; 144:592-598
27. 27. Seekamp A, Warren JS, Remick DG, et al: Requirements for tumor necrosis factor-alpha and interleukin-1 in limb ischemia-reperfusion injury and associated lung injury. Am J Pathol 1993; 143:453-463
28. 28. Kawamura T, Wakusawa R, Okada K, et al: Elevation of cytokines during open heart surgery with cardiopulmonary bypass: Participation of interleukin 8 and 6 in reperfusion injury. Can J Anaesth 1993; 40:1016-1021
29. 29. Latini R, Bianchi M, Correale E, et al: Cytokines in acute myocardial infarction: Selective increase in circulating tumor necrosis factor, its soluble receptor and interleukin-1 receptor antagonist. J Cardiovasc Pharmacol 1994; 23:1-6
30. 30. Airaghi L, Lettino M, Manfredi MG, et al: Endogenous cytokine antagonists during myocardial ischemia and thrombolytic therapy. Am Heart J 1995; 130:204-211
31. 31. Akira S, Hirano T, Taga T, et al: Biology of multifunctional cytokines: IL-6 and related molecules (IL-1 and TNF). FASEB J 1990; 4:2860-2867
32. 32. Maruo N, Morita I, Shirao M, et al: IL-6 increases endothelial permeability in vitro. Endocrinology 1992; 131:710-714
33. 33. Youker K, Smith WC, Anderson DC, et al: Neutrophil adherence to isolated adult cardiac myocytes: Induction by cardiac lymph collected during ischemia and reperfusion. J Clin Invest 1992; 89:602-609
34. 34. Finkel MS, Hoffman RA, Shen Li et al: Interleukin-6 (IL-6) as a mediator of stunned myocardium. Am J Card 1993; 71:1231-1232
35. 35. Paccaud JP, Shifferli JA, Baggiolini M: NAP-1/IL-8 induces up-regulation of CR 1 receptors in human neutrophil leukocyte. Biochem Biophys Res Commun 1990; 166: 187-192
36. 36. Miller EJ, Cohen AB, Nagao S, et al: Elevated levels of NAP-1/interleukin-8 are present in the airspaces of patients with the adult respiratory distress syndrome and are associated with increased mortality. Am Rev Respir Dis 1992; 146:427-432
37. 37. Sottile A, Venza M, Venza I, et al: Prostaglandins affect the respiratory burst of human neutrophils. Immunopharmacol Immunotoxicol 1995; 17:311-321
38. 1 in osteoblasts. J Clin Invest 1994; 93: 2490-2496
39. 39. Natori S, Fujii Y, Kurosawa H, et al: Prostaglandin E1 protects against ischemia-reperfusion injury of the liver by inhibition of neutrophil adherence to endothelial cells. Transplantation 1997; 64:1514-1520
40. 40. Miller LC, Lynch EA, Isa S, et al: Balance of synovial fluid IL-1 and IL-1 receptor antagonist and recovery from Lyme arthritis. Lancet 1993; 341:146-148
41. 41. Girardin E, Roux-Lombard P, Grau GE, et al: Imbalance between tumor necrosis factor alpha and soluble TNF receptor levels in severe meningococcemia. Immunol 1992; 76:20-23
42. 42. Hennecy CS, Bourne HR, Lichtenstein LM: The role of cyclic 3,5 adenosine monophosphate in the specific cytolytic activity of lymphocytes. J Immunol 1972; 108:1526-1534
43. 43. Pober JS, Slowik MR, De Luca LG, et al: Elevated cAMP inhibited endothelial cell synthesis and expression of TNF-induced endothelial leukocyte adhesion molecule-1 and vascular cell adhesion molecule-1 but not ICAM-1. J Immunol 1993; 150:5114-5123
44. 2. Naunyn Schmiedebergs Arch Pharmacol 1990; 341:308-315